Aspirin/Propoxyphene Napsylate

阿司匹林/萘磺酸丙氧芬

Report date: 2022/08/29 20:00:24

Base Information

Drug NameAspirin/Propoxyphene Napsylate
Drug Alias Name萘磺酸丙氧芬阿司匹林Propoxyphene Napsylate/Aspirinacetylsalicylic acid/Propoxyphene Napsylate阿司匹林萘磺酸丙氧芬Propoxyphene Napsylate/acetylsalicylic acid +[12] 
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsCyclooxygenases inhibitorsKappa opioid receptor antagonists +[4] 
TargetsMu opioid receptorKappa opioid receptorδ-opioid receptor +[4] 
Therapy Area/IndicationsAcute PainPain, Postoperative
Global Approved IndicationsAcute PainPain, Postoperative
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1971/09/09
Country/TerritoryUnited States
CombinationsYes AspirinPropoxyphene Napsylate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAaipharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAaipharma Litigation Llc
Active IndicationsN/A
Inactive IndicationsAcute PainPain, Postoperative

Other Information

ATC CodeN/A
Related LinksN/A